Document Detail


Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease.
MedLine Citation:
PMID:  8229245     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A cerebral vasodilatory capacity map, consisting of a 99mTc-DTPA-HSA SPECT image obtained after acetazolamide injection minus the baseline image, was produced in a patient with moyamoya disease. The map demonstrated diminished capacity in the posterior region of the right cerebral hemisphere. Subsequently, cerebral infarction occurred in the corresponding area. This observation suggests that regions of low vasodilatory capacity identified by cerebral vasodilatory capacity mapping may be at high risk of ischemic stroke.
Authors:
Y Inoue; T Momose; K Machida; N Honda; K Tsutsumi
Related Documents :
22118595 - Head ultrasound and mr imaging in the evaluation of neonatal encephalopathy: competitiv...
1328005 - Hypothalamopituitary deficiency and precocious puberty following hyperhydration in diab...
12665135 - Magnetic resonance imaging of a cerebral cavernous haemangioma in a dog.
9159375 - Mr detection of secondary changes remote from ischemia: preliminary observations after ...
21611795 - Acetylsalicylic acid does not prevent digital subtraction angiography-related high sign...
12427815 - The effect of pelvic mr imaging on the diagnosis and treatment of women with presumed s...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of nuclear medicine : official publication, Society of Nuclear Medicine     Volume:  34     ISSN:  0161-5505     ISO Abbreviation:  J. Nucl. Med.     Publication Date:  1993 Nov 
Date Detail:
Created Date:  1993-11-29     Completed Date:  1993-11-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0217410     Medline TA:  J Nucl Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1984-6     Citation Subset:  IM    
Affiliation:
Department of Radiology, Saitama Medical Center, Saitama Medical School, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetazolamide / pharmacology*
Cerebral Infarction / diagnosis,  etiology
Cerebrovascular Circulation*
Humans
Male
Middle Aged
Moyamoya Disease / complications,  physiopathology,  radionuclide imaging*
Technetium Tc 99m Aggregated Albumin / diagnostic use*
Technetium Tc 99m Pentetate / diagnostic use*
Tomography, Emission-Computed, Single-Photon*
Vasodilation / drug effects*
Chemical
Reg. No./Substance:
0/Technetium Tc 99m Aggregated Albumin; 0/technetium Tc 99m DTPA HSA; 59-66-5/Acetazolamide; 65454-61-7/Technetium Tc 99m Pentetate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lobar primary pulmonary lymphoma: iodine-123-iodoamphetamine and thallium-201-chloride scintigraphic...
Next Document:  Increased cerebral perfusion after detachable balloon embolization of carotid cavernous fistula on t...